共 137 条
[1]
Gupta N(2017)Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline Am J Respir Crit Care Med 196 1337-1348
[2]
Finlay GA(2011)Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur Respir Rev 20 34-44
[3]
Kotloff RM(2013)Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry Lung 191 35-42
[4]
Strange C(2004)Survival and disease progression in UK patients with lymphangioleiomyomatosis Thorax 59 800-803
[5]
Wilson KC(2019)The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis Chest 155 288-296
[6]
Young LR(2007)The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors Respirology 12 523-530
[7]
Taveira-DaSilva AM(1995)Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors Am J Respir Crit Care Med 151 527-533
[8]
Johnson SR(2004)Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone Chest 126 1867-1874
[9]
Cottin V(2005)Standardisation of the measurement of lung volumes Eur Respir J 26 511-522
[10]
Sahn SA(2005)Standardisation of spirometry Eur Respir J 26 319-338